Wound Care - Ireland

Ireland

Highlights

Revenue in the Wound Care market amounts to US$19.86m in 2024. The market is expected to grow annually by 0.58% (CAGR 2024-2029).
In global comparison, most revenue is generated United States (US$1bn in 2024).
In relation to total population figures, per person revenues of US$3.90 are generated in 2024.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureMethodology

The Wound Care market in Ireland is experiencing significant growth and development due to several key factors. Customer preferences for advanced wound care products, increasing prevalence of chronic wounds, and a growing elderly population are driving the demand for wound care products and services in the country.

Customer preferences in the Irish market are shifting towards advanced wound care products that offer faster healing and improved patient outcomes. This trend is driven by the increasing awareness among healthcare professionals and patients about the benefits of advanced wound care solutions. Customers are seeking products that are easy to use, provide effective wound management, and promote faster healing.

As a result, there is a growing demand for products such as wound dressings, wound closure devices, and negative pressure wound therapy systems. The increasing prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, is also contributing to the growth of the wound care market in Ireland. Chronic wounds are a significant burden on the healthcare system, and their prevalence is expected to rise due to factors such as an aging population and the increasing prevalence of diabetes.

Healthcare providers are recognizing the importance of early intervention and effective wound care management in preventing complications and reducing healthcare costs. This has led to an increased focus on wound care products and services, driving the growth of the market. Ireland has a growing elderly population, which is another key driver of the wound care market.

As people age, they become more susceptible to chronic diseases and conditions that can lead to the development of wounds. The elderly population requires specialized wound care products and services to manage their wounds effectively. This has created a significant market opportunity for wound care companies to develop products tailored to the needs of this demographic.

In addition to customer preferences and demographic factors, there are also local special circumstances that are influencing the development of the wound care market in Ireland. The country has a well-established healthcare system with a strong focus on patient care and outcomes. This has led to the adoption of advanced wound care technologies and practices in healthcare facilities across the country.

The presence of specialized wound care clinics and wound care nurses further supports the growth of the market by providing specialized care to patients with complex wounds. Underlying macroeconomic factors, such as favorable government policies and investments in healthcare infrastructure, are also contributing to the growth of the wound care market in Ireland. The government has implemented initiatives to improve access to healthcare services and promote the adoption of advanced wound care technologies.

These initiatives have created a favorable environment for companies operating in the wound care market and have stimulated investment in research and development. Overall, the Wound Care market in Ireland is experiencing growth and development due to customer preferences for advanced wound care products, the increasing prevalence of chronic wounds, a growing elderly population, local special circumstances, and underlying macroeconomic factors. These factors are driving the demand for wound care products and services and creating opportunities for companies operating in the market.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.